{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:10:28Z","timestamp":1780758628498,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007217","name":"Health Services Research and Development","doi-asserted-by":"publisher","award":["I01CX002816-01A1"],"award-info":[{"award-number":["I01CX002816-01A1"]}],"id":[{"id":"10.13039\/100007217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ajt.2025.08.013","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T16:41:39Z","timestamp":1755621699000},"page":"2303-2312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Sodium glucose cotransporter 2 inhibitor use after heart transplant: Current knowledge and potential applications"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7048-2955","authenticated-orcid":false,"given":"Lisa M.","family":"Raven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8888-1695","authenticated-orcid":false,"given":"Lina","family":"Brinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3873-2501","authenticated-orcid":false,"given":"Konstantinos","family":"Sideris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1430-0499","authenticated-orcid":false,"given":"Christopher A.","family":"Muir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7268-3689","authenticated-orcid":false,"given":"Spencer","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3312-315X","authenticated-orcid":false,"given":"Srinivasan","family":"Beddhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5378-2825","authenticated-orcid":false,"given":"Peter S.","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7362-0513","authenticated-orcid":false,"given":"Josef","family":"Stehlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajt.2025.08.013_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/CIRCULATIONAHA.117.029753","article-title":"Honoring 50 years of clinical heart transplantation in circulation: in-depth state-of-the-art review","volume":"137","author":"Stehlik","year":"2018","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ajt.2025.08.013_bib2","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.healun.2021.07.015","article-title":"The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-eighth adult heart transplantation report\u20142021; focus on recipient characteristics","volume":"40","author":"Khush","year":"2021","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2025.08.013_bib3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/ckj\/sfz019","article-title":"Sodium-glucose cotransporter inhibitors: beyond glycaemic control","volume":"12","author":"Vergara","year":"2019","journal-title":"Clin Kidney J"},{"issue":"5","key":"10.1016\/j.ajt.2025.08.013_bib4","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/ndt\/gfn759","article-title":"Chronic kidney disease after heart transplantation","volume":"24","author":"Hamour","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2025.08.013_bib5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/TP.0000000000003647","article-title":"New-onset diabetes mellitus after adult heart transplantation and the risk of renal dysfunction or mortality","volume":"106","author":"Vest","year":"2022","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.ajt.2025.08.013_bib6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/TP.0b013e31824e7620","article-title":"Incidence, determinants, and outcome of chronic kidney disease after adult heart transplantation in the United Kingdom","volume":"93","author":"Thomas","year":"2012","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.ajt.2025.08.013_bib7","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.healun.2019.08.004","article-title":"The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult heart transplantation report\u20142019; focus theme: donor and recipient size match","volume":"38","author":"Khush","year":"2019","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"10.1016\/j.ajt.2025.08.013_bib8","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/cpt.1307","article-title":"A model-based meta-analysis of 24 antihyperglycemic drugs for type 2 diabetes: comparison of treatment effects at therapeutic doses","volume":"105","author":"Maloney","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.ajt.2025.08.013_bib9","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl Sci"},{"issue":"2","key":"10.1016\/j.ajt.2025.08.013_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jacc.2023.10.030","article-title":"Hyperuricemia and gout reduction by SGLT2 inhibitors in diabetes and heart failure: JACC review topic of the week","volume":"83","author":"Packer","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ajt.2025.08.013_bib11","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.healun.2015.08.003","article-title":"The registry of the international society for heart and lung transplantation: thirty-second official adult heart transplantation report\u20142015; focus theme: early graft failure","volume":"34","author":"Lund","year":"2015","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.ajt.2025.08.013_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15441","article-title":"Association of early post-transplant hyperglycaemia and diabetes mellitus on outcomes following heart transplantation","volume":"42","author":"Muir","year":"2025","journal-title":"Diabet Med"},{"issue":"10","key":"10.1016\/j.ajt.2025.08.013_bib13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.5500\/wjt.v11.i10.432","article-title":"Impact of immunosuppression on incidence of post-transplant diabetes mellitus in solid organ transplant recipients: systematic review and meta-analysis","volume":"11","author":"Kotha","year":"2021","journal-title":"World J Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2025.08.013_bib14","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1111\/ajt.14316","article-title":"Effect of empagliflozin on tacrolimus-induced pancreas islet dysfunction and renal injury","volume":"17","author":"Jin","year":"2017","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2025.08.013_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2019.06.007","article-title":"Correction of hypomagnesemia by dapagliflozin in patients with type 2 diabetes: a post hoc analysis of 10 randomized, placebo-controlled trials","volume":"33","author":"Toto","year":"2019","journal-title":"J Diabetes Complications"},{"issue":"9","key":"10.1016\/j.ajt.2025.08.013_bib16","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/MAT.0000000000001566","article-title":"Weight gain after heart transplantation in adults: systematic review and meta-analysis","volume":"68","author":"Miura","year":"2022","journal-title":"ASAIO J"},{"issue":"6","key":"10.1016\/j.ajt.2025.08.013_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004007","article-title":"Effect of sodium-glucose cotransport-2 inhibitors on blood pressure in people with type 2 diabetes mellitus: a systematic review and meta-analysis of 43 randomized control trials with 22 528 patients","volume":"6","author":"Mazidi","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.ajt.2025.08.013_bib18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacbts.2019.04.003","article-title":"Cardiac microvascular endothelial enhancement of cardiomyocyte function is impaired by inflammation and restored by empagliflozin","volume":"4","author":"Juni","year":"2019","journal-title":"JACC Basic Transl Sci"},{"issue":"1","key":"10.1016\/j.ajt.2025.08.013_bib19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12933-022-01607-4","article-title":"Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report","volume":"21","author":"Leccisotti","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"10.1016\/j.ajt.2025.08.013_bib20","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00125-017-4509-7","article-title":"Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na(+)\/H(+) exchanger, lowering of cytosolic Na(+) and vasodilation","volume":"61","author":"Uthman","year":"2018","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.ajt.2025.08.013_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.mcna.2016.08.011","article-title":"Hypertension in patients with cardiac transplantation","volume":"101","author":"Bennett","year":"2017","journal-title":"Med Clin North Am"},{"issue":"7","key":"10.1016\/j.ajt.2025.08.013_bib22","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1097\/TP.0000000000002704","article-title":"Cardiac allograft vasculopathy: the enduring enemy of cardiac transplantation","volume":"103","author":"Nikolova","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.ajt.2025.08.013_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yjmcc.2022.03.005","article-title":"Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: evidence for potential off-target effects","volume":"167","author":"Dyck","year":"2022","journal-title":"J Mol Cell Cardiol"},{"issue":"7","key":"10.1016\/j.ajt.2025.08.013_bib24","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.cardfail.2015.04.014","article-title":"The importance of NLRP3 inflammasome in heart failure","volume":"21","author":"Butts","year":"2015","journal-title":"J Card Fail"},{"issue":"8","key":"10.1016\/j.ajt.2025.08.013_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14346","article-title":"Prevalence of iron deficiency in heart transplant recipients","volume":"35","author":"Brautaset Englund","year":"2021","journal-title":"Clin Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2025.08.013_bib26","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.healun.2020.06.007","article-title":"The cardioprotective potential of the sodium-glucose cotransporter 2 inhibitor empagliflozin in donor heart preservation","volume":"39","author":"Villanueva","year":"2020","journal-title":"J Heart Lung Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2025.08.013_bib27","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1210\/clinem\/dgab274","article-title":"Clinical adverse events associated with sodium-glucose cotransporter 2 inhibitors: a meta-analysis involving 10 randomized clinical trials and 71 553 individuals","volume":"106","author":"Lin","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ajt.2025.08.013_bib28","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/ckj\/sfad007","article-title":"Sodium-glucose cotransporter-2 inhibitor therapy in kidney transplant patients with type 2 or post-transplant diabetes: an observational multicentre study","volume":"16","author":"S\u00e1nchez Fructuoso","year":"2023","journal-title":"Clin Kidney J"},{"issue":"3","key":"10.1016\/j.ajt.2025.08.013_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/15269248231189880","article-title":"Safety and efficacy of sodium-glucose cotransporter-2 inhibitors in solid organ transplant recipients","volume":"33","author":"Sweiss","year":"2023","journal-title":"Prog Transplant"},{"issue":"6","key":"10.1016\/j.ajt.2025.08.013_bib30","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2337\/dc19-0093","article-title":"Efficacy and safety of empagliflozin in renal transplant recipients with posttransplant diabetes mellitus","volume":"42","author":"Halden","year":"2019","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.ajt.2025.08.013_bib31","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001228","article-title":"Safety and efficacy of sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients with pretransplant type 2 diabetes mellitus: a retrospective, single-center, inverse probability of treatment weighting analysis of 85 transplant patients","volume":"7","author":"Hisadome","year":"2021","journal-title":"Transplant Direct"},{"issue":"9","key":"10.1016\/j.ajt.2025.08.013_bib32","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1097\/TP.0000000000004228","article-title":"The efficacy and safety of SGLT2 inhibitor in diabetic kidney transplant recipients","volume":"106","author":"Lim","year":"2022","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.ajt.2025.08.013_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54171-8","article-title":"The outcomes of SGLT-2 inhibitor utilization in diabetic kidney transplant recipients","volume":"15","author":"Sheu","year":"2024","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.ajt.2025.08.013_bib34","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1111\/dom.15769","article-title":"Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors for the treatment of diabetes mellitus in liver transplant recipients","volume":"26","author":"Zheng","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.ajt.2025.08.013_bib35","first-page":"47","article-title":"Efficacy and safety of SGLT-2 inhibitors for treatment of diabetes mellitus among kidney transplant patients: a systematic review and meta-analysis","volume":"8","author":"Chewcharat","year":"2020","journal-title":"Med Sci (Basel)"},{"issue":"3","key":"10.1016\/j.ajt.2025.08.013_bib36","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/ajt.15223","article-title":"Empagliflozin in posttransplantation diabetes mellitus: a prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety","volume":"19","author":"Schwaiger","year":"2019","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.ajt.2025.08.013_bib37","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2017.05.005","article-title":"Empagliflozin in the management of diabetes mellitus after cardiac transplantationResearch Correspondenceretain\u2013>","volume":"36","author":"Muir","year":"2017","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"10.1016\/j.ajt.2025.08.013_bib38","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000885","article-title":"Efficacy and safety of empagliflozin in the management of diabetes mellitus in heart transplant recipients","volume":"5","author":"Cehic","year":"2019","journal-title":"Transplant Direct"},{"issue":"6","key":"10.1016\/j.ajt.2025.08.013_bib39","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.healun.2021.02.012","article-title":"Effects of GLP-1 receptor agonists and SGLT-2 inhibitors in heart transplant patients with type 2 diabetes: initial report from a cardiometabolic center of excellence","volume":"40","author":"Sammour","year":"2021","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"10.1016\/j.ajt.2025.08.013_bib40","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/joim.20077","article-title":"Effects of SGLT2 inhibitors on transplant survival and key clinical outcomes in heart transplant recipients with diabetes","volume":"297","author":"Yen","year":"2025","journal-title":"J Intern Med"},{"key":"10.1016\/j.ajt.2025.08.013_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhlto.2025.100255","article-title":"Sodium glucose cotransporter 2 inhibitors are associated with renal stabilization in heart transplantation","volume":"8","author":"Raven","year":"2025","journal-title":"JHLT Open"},{"issue":"2","key":"10.1016\/j.ajt.2025.08.013_bib42","first-page":"242","article-title":"Are There any renoprotective effects of SGLT2 inhibitors in heart transplant recipients with diabetes?","volume":"41","author":"Lu","year":"2025","journal-title":"Acta Cardiol Sin"},{"issue":"8","key":"10.1016\/j.ajt.2025.08.013_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.102520","article-title":"Diabetes therapy with SGLT2i after heart transplant: a multi-institutional analysis","volume":"13","author":"Brinker","year":"2025","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.ajt.2025.08.013_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2022.100729","article-title":"Use of sodium-glucose co-transporter 2 inhibitors in solid organ transplant recipients with pre-existing type 2 or post-transplantation diabetes mellitus: a systematic review","volume":"37","author":"Lin","year":"2023","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.ajt.2025.08.013_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154936","article-title":"Sodium\/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts","volume":"127","author":"Marfella","year":"2022","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.ajt.2025.08.013_bib46","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/j.transproceed.2021.08.017","article-title":"Sodium-glucose cotransporter-2 inhibitor\u2013associated euglycemic diabetic ketoacidosis after orthotopic heart transplant in a prediabetic patient: a case report","volume":"53","author":"Cha","year":"2021","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ajt.2025.08.013_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhlto.2024.100088","article-title":"Effect of sodium glucose cotransporter 2 inhibition immediately prior to heart transplantation","volume":"5","author":"Raven","year":"2024","journal-title":"JHLT Open"},{"key":"10.1016\/j.ajt.2025.08.013_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhlto.2024.100060","article-title":"Fournier\u2019s gangrene in recent transplant recipient on empagliflozin","volume":"4","author":"Raven","year":"2024","journal-title":"JHLT Open"},{"issue":"2","key":"10.1016\/j.ajt.2025.08.013_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.trre.2016.09.001","article-title":"Drug-drug interactions between immunosuppressants and antidiabetic drugs in the treatment of post-transplant diabetes mellitus","volume":"31","author":"Vanhove","year":"2017","journal-title":"Transplant Rev (Orlando)"},{"issue":"3","key":"10.1016\/j.ajt.2025.08.013_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-069641","article-title":"Sodium glucose co-transporter 2 inhibition with empagliflozin on metabolic, cardiac and renal outcomes in recent cardiac transplant recipients (EMPA-HTx): protocol for a randomised controlled trial","volume":"13","author":"Raven","year":"2023","journal-title":"BMJ Open"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525029223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525029223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:02:37Z","timestamp":1772892157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613525029223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1600613525029223"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2025.08.013","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium glucose cotransporter 2 inhibitor use after heart transplant: Current knowledge and potential applications","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2025.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Society of Transplantation & American Society of Transplant Surgeons.","name":"copyright","label":"Copyright"}]}}